Cognetivity Neurosciences launches in the Middle East
Dubai launch grants access to wealthy and innovative national healthcare system, and provides...
Read More
Tag: CGN
Former Director of Research at Alzheimer’s Research UK Carol Routledge joins advisory board at Cognetivity Neurosciences
Dr Routledge brings extensive experience in senior roles at leading multinational pharmaceutical...
Read More
Cognetivity Neurosciences Files Key New Patent for Non-Invasive, AI-based System Capable of Providing Early Stage Detection of Alzheimer’s at Scale
Newly-filed patent will enable platform technology to be licensed for much-needed biomarker...
Read More
Cognetivity Neurosciences and InterSystems Partner to Fast-Track Integration of Early Dementia Detection Platform with Global Healthcare Systems
Partnership with the world-leading technology provider InterSystems supports seamless integration...
Read More
Former UK Health Minister Lord O’Shaughnessy Joins Advisory Board at Cognetivity Neurosciences
Lord O’Shaughnessy brings a wealth of experience in healthcare policy, government and life...
Read More
Cognetivity Neurosciences Announces Commercial Deployment of OptiMind Wellness App with Market-Leading Telehealth Company
Cognetivity’s unique cognition-monitoring technology to be deployed to measure positive...
Read MoreCognetivity Neurosciences Selected to Join UK Innovation Agency Programme for UK’s Most Outstanding Scaling Businesses
Cognetivity joins select group of UK scaleups deemed capable of achieving at least 50% annual growth VANCOUVER, BC, Feb. 11, 2021 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or...
Read MoreCognetivity Neurosciences expands ongoing UK government-funded study to include Covid-safe remote cognitive assessment
Cognetivity’s iPad-based Integrated Cognitive Assessment (ICA) well suited to remote use as global demand for telehealth continues to surge VANCOUVER, BC, Jan. 12, 2021 /CNW/ – Cognetivity Neurosciences...
Read MoreCognetivity Neurosciences Provides Update on 2020 Corporate Achievements
Cognetivity Neurosciences Provides Update on 2020 Corporate Achievements Cognetivity reached several major milestones including first clinical deployment of its technology within the UK’s NHS, providing a strong platform for...
Read MoreCognetivity Neurosciences Closes Oversubscribed Non-Brokered Private Placement
VANCOUVER, Dec. 22, 2020 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) announces that pursuant to its news releases dated December 2,...
Read MoreCOGNETIVITY NEUROSCIENCES ADVANCES TO TMCX FULL ACCELERATOR PROGRAM TO FAST TRACK US COMMERCIAL DEVELOPMENT
Cognetivity one of only seven health tech innovators selected to advance to full accelerator programCohorts receive increased resources and network support to accelerate US market penetrationVANCOUVER, BC, Dec. 23, 2020 /CNW/...
Read MoreCognetivity Neurosciences’ CMO to Present at Alzheimer’s Association International Conference (AAIC) 2019
AAIC is the Largest and Most Influential International Meeting Dedicated to Advancing Dementia Science Cognetivity’s Chief Medical Officer to Present Latest Company Research and Platform Capability Focused on Early...
Read More
